ellume Logo

COVID-19 Home Test

The test is suitable for ages 2 years and above for over-the-counter home use. Clinically proven for use for people with and without symptoms, with accurate test results in 15 minutes.

Now available for sale in the U.S. at ellumecovidtest.com

Learn More
Mother testing sick child with the ellume covid home test
COVID-19 home test components and mobile app

How it works

The test includes a nasal swab with protective child adapter, a dropper, processing fluid, and a Bluetooth® connected analyzer for use with an app on your phone.

The app will guide you through the test including an integrated information video and step-by-step instructions. The sample is analyzed and the result is displayed on your phone after 15 minutes. Results are saved within the app and can be shared via email.

The Ellume COVID-19 Home Test complies with CDC reporting requirements and automatically reports the required data to health authorities through our secure encrypted, HIPAA compliant, cloud connection.

Learn More
Ellume COVID Home mobile app showing test result

Features and benefits

Ground breaking, patented fluorescent detection technology
Results in 15 minutes
96% accurate
Suitable for ages 2 years and above
Patented, user-friendly nasal swab with child adapter
Designed and extensively tested for personal use
Step-by-step instructions in the app
Clear results written in words, no faint lines to interpret
Ideal for travel and event testing
Internal test control ensuring sufficient sample for accurate results

Coronavirus: The facts

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. COVID-19 is a respiratory illness primarily spread from person to person. COVID-19 symptoms can range from mild (or no symptoms) to severe illness. While multiple vaccines for COVID-19 are now authorized, rapid diagnosis remains pivotal to minimizing transmission.

The Ellume COVID-19 Home Test has not been FDA cleared or approved; but has been authorized by the FDA under an emergency use authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetics Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
We use cookies
Ellume Limited values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website and features; functional cookies remember your preferences; and advertising cookies help us share relevant content. Cookies Policy.